Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Bone grafts and biomaterials substitutes for bone defect repair: A review
2017 Standout
Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era
2008
Ozone therapy: A clinical review
2011
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
1997
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
2001 Standout
Ozone as Janus: this controversial gas can be either toxic or medically useful
2004
Anatomic, Physiologic and Metabolic Imaging in Neuro-Oncology
2008
Risk Factors of Cerebral Vein and Sinus Thrombosis
2007
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
Multiple sclerosis
2008 Standout
The ozone paradox: Ozone is a strong oxidant as well as a medical drug
2009
Psychiatric Disturbances in Metachromatic Leukodystrophy
1992
The effects of air pollution on adverse birth outcomes
2014 Standout
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Primary brain tumours in adults
2012 Standout
Persistence of Cryptococcomas on Neuroimaging
2000
Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy
2003
Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
2013 Standout
A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice
2008
Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children
2000
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Multiple sclerosis
2002 Standout
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.
2000
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
1997
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Development of a bovine collagen–apatitic calcium phosphate cement for potential fracture treatment through vertebroplasty
2012
Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002
Works of C.F. Andreula being referenced
Treatment of herniated lumbar disc by intradiscal and intraforaminal oxygen-ozone (O2-O3) injection
2004
Case of Landau‐Kleffner Syndrome Secondary to Inflammatory Demyelinating Disease
1993
CNS Cryptococcosis in AIDS
1993
A Controlled Trial of Mitoxantrone in Multiple Sclerosis: Serial MRI Evaluation at One Year
1994
Dural sinus thrombosis in spontaneous intracranial hypotension
2006
Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV
1998
RATIONALE FOR THE USE OF CONTRAST MEDIA IN MR IMAGING
1997
Percutaneous vertebroplasty: indications, contraindications, technique, and complications
2005
Minimally invasive oxygen-ozone therapy for lumbar disk herniation.
2003
Clinical and CT parameters in degenerative cerebellar atrophy in aged patients
1984